Trial record 1 of 1 for:
CIBI130A101
A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05923008 |
Recruitment Status :
Recruiting
First Posted : June 28, 2023
Last Update Posted : November 29, 2023
|
Sponsor:
Innovent Biologics (Suzhou) Co. Ltd.
Information provided by (Responsible Party):
Innovent Biologics (Suzhou) Co. Ltd.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | November 30, 2024 |
Estimated Study Completion Date : | October 31, 2026 |